Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Murphy, Richard Gaynor, Steve Paul, Joseph Di Bussolo, Mickey Urdea, Elena Grigorenko

Premium

Nanosys has appointed Matthew Murphy vice president of intellectual property, the Palo Alto-based nanotechnology company said last week. Prior to joining Nanosys, Murphy served as vice president for intellectual property at Caliper Technologies, where he represented the company for six years and built a portfolio of 500 patents and patent applications. In a previous position, Murphy worked at the law firm Townsend, Townsend, and Crew, in the chemical and biotechnology practice group.

Richard Gaynor has joined Lilly Research Laboratories in Indianapolis as vice president for cancer research and clinical investigation. Before joining Lilly, Gaynor was professor of medicine and microbiology at the University of Texas Southwestern Medical School in Dallas. He was also director of the university’s Harold Simmons Comprehensive Cancer Center and chief of its hematology-oncology division. Gaynor will report to Steve Paul, group vice president for Lilly Research Laboratories.

Joseph Di Bussolo has joined Cohesive Technologies as director of field applications, the Franklin, Mass.-based chromatography instrumentation company said. In his new role Di Bussolo will collaborate with customers on method development, training, and other support issues associated with Cohesive’s products. Prior to joining Cohesive, Di Bussolo served as a senior staff scientist at PerkinElmer Instruments’ molecular spectroscopy and chromatography solutions business unit.

Mickey Urdea has been appointed to the board of directors of Quantum Dot, based in Hayward, Calif. Urdea is a founder of Chiron and a former senior vice president of nucleic acid diagnostics at Bayer. At Chiron, he developed branched DNA hybridization assays. After leaving Bayer, Urdea, who holds a PhD in biochemistry from Washington State University, became a biotechnology consultant for several firms.

Elena Grigorenko has joined the advisory board of NuGEN in San Carlos, Calif. She has been a researcher at Millennium Pharmaceuticals since 2000, where she has been responsible for projects that include microarray platform evaluations and RNA labeling improvements. Prior to that, Grigorenko was an instructor and assistant professor at the Wake Forest University school of medicine where she directed the molecular biology/microarray core facility. She holds a PhD in biochemistry from the Institute of Biological Physics of the Russian Academy of Sciences.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.